Cohen Capital Management’s Pfizer PFE Stock Holding History

Cohen Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Hold	67,037	–	–	0.22%	78
2026 Q1	$1.88M	Hold	67,037	–	–	0.29%	70
2025 Q4	$1.67M	Hold	67,037	–	–	0.25%	73
2025 Q3	$1.71M	Hold	67,037	–	–	0.27%	70
2025 Q2	$1.62M	Hold	67,037	–	–	0.26%	69
2025 Q1	$1.7M	Buy	67,037 +1	+0%	+$26	0.29%	69
2024 Q4	$1.78M	Hold	67,036	–	–	0.3%	68
2024 Q3	$1.94M	Hold	67,036	–	–	0.31%	67
2024 Q2	$1.88M	Buy	67,036 +15	+0%	+$413	0.32%	68
2024 Q1	$1.86M	Hold	67,021	–	–	0.33%	67
2023 Q4	$1.93M	Hold	67,021	–	–	0.37%	65
2023 Q3	$2.22M	Hold	67,021	–	–	0.46%	58
2023 Q2	$2.46M	Hold	67,021	–	–	0.48%	59
2023 Q1	$2.73M	Hold	67,021	–	–	0.55%	51
2022 Q4	$3.43M	Hold	67,021	–	–	0.7%	37
2022 Q3	$2.93M	Hold	67,021	–	–	0.65%	44
2022 Q2	$3.51M	Hold	67,021	–	–	0.72%	39
2022 Q1	$3.47M	Hold	67,021	–	–	0.61%	49
2021 Q4	$3.96M	Hold	67,021	–	–	0.65%	48
2021 Q3	$2.88M	Hold	67,021	–	–	0.5%	64
2021 Q2	$2.63M	Hold	67,021	–	–	0.45%	71
2021 Q1	$2.43M	Hold	67,021	–	–	0.45%	68
2020 Q4	$2.47M	Sell	67,021 -6,238	-9%	-$229K	0.49%	62
2020 Q3	$2.55M	Hold	73,259	–	–	0.58%	58
2020 Q2	$2.27M	Hold	73,259	–	–	0.56%	55
2020 Q1	$2.27M	Hold	73,259	–	–	0.67%	47
2019 Q4	$2.72M	Hold	73,259	–	–	0.59%	54
2019 Q3	$2.5M	Hold	73,259	–	–	0.57%	54
2019 Q2	$3.01M	Hold	73,259	–	–	0.7%	44
2019 Q1	$2.95M	Hold	73,259	–	–	0.71%	43
2018 Q4	$3.03M	Hold	73,259	–	–	0.84%	40
2018 Q3	$3.06M	Hold	73,259	–	–	0.69%	49
2018 Q2	$2.52M	Hold	73,259	–	–	0.58%	57
2018 Q1	$2.46M	Hold	73,259	–	–	0.58%	57
2017 Q4	$2.52M	Hold	73,259	–	–	0.59%	53
2017 Q3	$2.48M	Hold	73,259	–	–	0.6%	52
2017 Q2	$2.33M	Hold	73,259	–	–	0.58%	54
2017 Q1	$2.38M	Hold	73,259	–	–	0.6%	56
2016 Q4	$2.26M	Hold	73,259	–	–	0.62%	52
2016 Q3	$2.35M	Hold	73,259	–	–	0.66%	49
2016 Q2	$2.45M	Hold	73,259	–	–	0.71%	47
2016 Q1	$2.24M	Hold	73,259	–	–	0.68%	50
2015 Q4	$2.24M	Hold	73,259	–	–	0.68%	50
2015 Q3	$2.18M	Hold	73,259	–	–	0.65%	53
2015 Q2	$2.33M	Hold	73,259	–	–	0.6%	61
2015 Q1	$2.42M	Hold	73,259	–	–	0.62%	61
2014 Q4	$2.17M	Hold	73,259	–	–	0.56%	62
2014 Q3	$2.06M	Hold	73,259	–	–	0.55%	64
2014 Q2	$2.06M	Sell	73,259 -4,377	-6%	-$125K	0.53%	66
2014 Q1	$2.37M	Buy	77,636 +4,377	+6%	+$131K	0.64%	62
2013 Q4	$2.13M	Hold	73,259	–	–	0.6%	64
2013 Q3	$2M	Hold	73,259	–	–	0.62%	62
2013 Q2	$1.95M	Buy	+73,259	New	+$2.02M	0.62%	62

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Cohen Capital Management's PFE Position: Q2 2026 in Review

Cohen Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 67,037 shares worth $1.61M. The position accounts for 0.22% of the portfolio, ranked #78.

Cohen Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.96M in Q4 2021. 446 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cohen Capital Management held 67,037 shares of Pfizer worth $1.61M as of Q2 2026.
Cohen Capital Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.22% of Cohen Capital Management's portfolio in Q2 2026, its #78 holding.
Cohen Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Cohen Capital Management's Pfizer position peaked at $3.96M in Q4 2021.
446 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cohen Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.